Heron Therapeutics
HRTX
#8256
Rank
HK$1.86 B
Marketcap
HK$10.20
Share price
0.00%
Change (1 day)
-19.09%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.82 Billion

According to Heron Therapeutics's latest financial reports the company's total liabilities are HK$1.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$2.07 B3.4%
2023-12-31HK$2.00 B8%
2022-12-31HK$1.85 B4.26%
2021-12-31HK$1.77 B96.02%
2020-12-31HK$0.90 B6.95%
2019-12-31HK$0.84 B17.75%
2018-12-31HK$0.72 B-10.6%
2017-12-31HK$0.80 B17.15%
2016-12-31HK$0.68 B349.85%
2015-12-31HK$0.15 B44.79%
2014-12-31HK$0.10 B94.85%
2013-12-31HK$54.21 M68.39%
2012-12-31HK$32.19 M12.26%
2011-12-31HK$28.68 M131.08%
2010-12-31HK$12.41 M-25.71%
2009-12-31HK$16.7 M-48.54%
2008-12-31HK$32.47 M-44.29%
2007-12-31HK$58.29 M44.35%
2006-12-31HK$40.38 M88.29%
2005-12-31HK$21.44 M-3.51%
2004-12-31HK$22.22 M51.55%
2003-12-31HK$14.66 M-19.01%
2002-12-31HK$18.1 M-46.43%
2001-12-31HK$33.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alkermes
ALKS
HK$4.64 B 154.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
HK$4.44 B 143.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$1.68 B-7.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$4.09 B 124.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
HK$0.45 B-75.00%๐Ÿ‡บ๐Ÿ‡ธ USA